Photo by shapelined from unsplash
Key Points High surface IgM expression associates with shorter time to new treatment following ibrutinib therapy. Cells with high surface IgM expression retain residual signaling capacity downstream of BTK during… Click to show full abstract
Key Points High surface IgM expression associates with shorter time to new treatment following ibrutinib therapy. Cells with high surface IgM expression retain residual signaling capacity downstream of BTK during ibrutinib therapy.
Keywords:
surface igm;
ibrutinib;
high surface;
levels associate;
igm levels
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!